Skip to main content

FULLER & THALER ASSET MANAGEMENT, INC.

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1082327 SAN MATEO, CA

Position in HALO

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$94,701,240
+$1,855,843 QoQ
Shares Held
1,465,283
+6.2% QoQ
Ownership
1.24%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 94.33761259770297.ToString("F0")% Shared 0.ToString("F0")% None 5.66238740229703.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

FULLER & THALER ASSET MANAGEMENT, INC. holds $778,296,159 across 4 Biotechnology names. HALO ranks #3 (12.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 HALO
Halozyme Therapeutics, Inc.
This page
1,465,283 $94,701,240

All Filings in HALO

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $94,701,240 1,465,283
2025-12-31 $92,845,397 1,379,575
2025-09-30 $100,562,634 1,371,184
2025-06-30 $64,661,276 1,243,008
2025-03-31 $72,106,512 1,130,019
2024-12-31 $42,448,204 887,852
2024-09-30 $47,139,658 823,544
2024-06-30 $37,519,762 716,573
2024-03-31 $23,120,925 568,361
2023-12-31 $15,141,846 409,682
2023-09-30 $14,072,650 368,394
2023-06-30 $12,191,732 338,002
2021-12-31 $11,229,165 279,263
2021-09-30 $11,519,925 283,184
2021-06-30 $13,978,696 307,833
2021-03-31 $15,817,644 379,411
2020-12-31 $15,927,285 372,917
2020-09-30 $9,599,321 365,271
2020-06-30 $10,708,074 399,406
2020-03-31 $6,641,890 369,199